CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP MOUTHWASH

Kraj: Kanada

Język: angielski

Źródło: Health Canada

Składnik aktywny:

CHLORHEXIDINE GLUCONATE

Dostępny od:

SAGE PRODUCTS LLC

Kod ATC:

A01AB03

INN (International Nazwa):

CHLORHEXIDINE

Dawkowanie:

0.12%

Forma farmaceutyczna:

MOUTHWASH

Skład:

CHLORHEXIDINE GLUCONATE 0.12%

Droga podania:

BUCCAL

Sztuk w opakowaniu:

15ML/473ML

Typ recepty:

Prescription

Dziedzina terapeutyczna:

MISCELLANEOUS ANTI-INFECTIVES

Podsumowanie produktu:

Active ingredient group (AIG) number: 0107629007; AHFS:

Status autoryzacji:

CANCELLED POST MARKET

Data autoryzacji:

2022-04-22

Charakterystyka produktu

_ _
_ _
_Page 1 of 19_
PRODUCT MONOGRAPH
CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP
Chlorhexidine Gluconate 0.12% Oral Rinse
Liquid, 0.12% Chlorhexidine Gluconate
Antigingivital Oral Rinse
Sage Product LLC
3909 Three Oaks Road
Cary, IL 60013
USA
Date of Preparation:
February 17, 2015
Submission Control No: 180308
_ _
_ _
_Page 2 of 19_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................6
DOSAGE AND ADMINISTRATION
................................................................................6
OVERDOSAGE
..................................................................................................................7
ACTION AND CLINICAL PHARMACOLOGY
..............................................................8
STORAGE AND STABILITY
............................................................................................9
SPECIAL HANDLING INSTRUCTIONS
.........................................................................9
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................10
PART II: SCIENTIFIC INFORMATION
...............................................................................11
PHARMACEUTICAL INFORMATION
..........................................................................11
CLINICAL TRIALS
..........................................................................................................12
DETAILED PHARMACOLOGY
.........................